What does CUSIP Y95308105 represent in this 13F holders report?

CUSIP Y95308105 is the security identifier for WVE - Wave Life Sciences Ltd. - Ordinary Shares, no par value used to aggregate holder disclosures.

How many institutions held WVE - Wave Life Sciences Ltd. - Ordinary Shares, no par value in Q1 2018?

79 institutional investors reported WVE - Wave Life Sciences Ltd. - Ordinary Shares, no par value for Q1 2018. Use the holders table for investor-level position and value details.

Wave Life Sciences Ltd. - Ordinary Shares, no par value (WVE)

CUSIP: Y95308105

Q1 2018 13F Holders as of 31 Mar 2018

Type / Class: Equity / Ordinary Shares, no par value
Shares outstanding: 188,679,245
Total 13F shares: 23,663,816
Share change: +1,443,616
Total reported value: $948,860,012
Price per share: $40.10
Number of holders: 79
Value change: +$61,087,976
Number of buys: 47
Number of sells: 30

Quarterly Holders Quick Answers

What is CUSIP Y95308105?
CUSIP Y95308105 identifies WVE - Wave Life Sciences Ltd. - Ordinary Shares, no par value in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q2 2018
Previous quarter: Q4 2017

Recent filing periods for CUSIP Y95308105:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of WVE - Wave Life Sciences Ltd. - Ordinary Shares, no par value (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
RA CAPITAL MANAGEMENT, L.P.	13F	Company	4%	7,512,049	$263,673,000	—	31 Dec 2017	13F
Redmile Group, LLC	13F	Company	1.2%	2,209,107	$77,540,000	—	31 Dec 2017	13F
PRICE T ROWE ASSOCIATES INC /MD/	13F	Company	0.92%	1,726,956	$60,616,000	—	31 Dec 2017	13F
FMR LLC	13F	Company	0.59%	1,108,649	$38,914,000	—	31 Dec 2017	13F
EcoR1 Capital, LLC	13F	Company	0.5%	936,163	$32,859,000	—	31 Dec 2017	13F
BlackRock Finance, Inc.	13F	Company	0.5%	934,733	$32,810,000	—	31 Dec 2017	13F
BB BIOTECH AG	13F	Company	0.45%	856,096	$30,049,000	—	31 Dec 2017	13F
JANUS HENDERSON GROUP PLC	13F	Company	0.38%	709,224	$24,894,000	—	31 Dec 2017	13F
PERCEPTIVE ADVISORS LLC	13F	Company	0.35%	662,798	$23,264,000	—	31 Dec 2017	13F
Boxer Capital, LLC	13F	Company	0.29%	550,000	$19,305,000	—	31 Dec 2017	13F
New Leaf Venture Partners, L.L.C.	13F	Company	0.24%	458,259	$16,085,000	—	31 Dec 2017	13F
EVENTIDE ASSET MANAGEMENT, LLC	13F	Company	0.23%	433,500	$15,216,000	—	31 Dec 2017	13F
ArrowMark Colorado Holdings LLC	13F	Company	0.22%	416,744	$14,628,000	—	31 Dec 2017	13F
BRIDGER MANAGEMENT, LLC	13F	Company	0.18%	337,949	$11,862,000	—	31 Dec 2017	13F
GREAT POINT PARTNERS LLC	13F	Company	0.18%	331,085	$11,621,000	—	31 Dec 2017	13F
DEERFIELD MANAGEMENT COMPANY, L.P.	13F	Company	0.17%	314,674	$11,045,000	—	31 Dec 2017	13F
VANGUARD GROUP INC	13F	Company	0.14%	261,770	$9,188,000	—	31 Dec 2017	13F
STATE STREET CORP	13F	Company	0.12%	232,939	$8,180,000	—	31 Dec 2017	13F
Cormorant Asset Management, LP	13F	Company	0.11%	202,079	$7,093,000	—	31 Dec 2017	13F
Foresite Capital Management III, LLC	13F	Company	0.09%	162,347	$5,698,000	—	31 Dec 2017	13F
BERYLSON CAPITAL PARTNERS, LLC	13F	Company	0.09%	162,238	$5,695,000	—	31 Dec 2017	13F
JPMORGAN CHASE & CO	13F	Company	0.09%	161,332	$5,662,000	—	31 Dec 2017	13F
CLOUGH CAPITAL PARTNERS L P	13F	Company	0.08%	159,403	$5,595,000	—	31 Dec 2017	13F
NORTHERN TRUST CORP	13F	Company	0.08%	152,865	$5,365,000	—	31 Dec 2017	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.07%	133,398	$4,682,000	—	31 Dec 2017	13F
Point72 Asset Management, L.P.	13F	Company	0.05%	100,000	$3,510,000	—	31 Dec 2017	13F
Artal Group S.A.	13F	Company	0.05%	92,078	$3,232,000	—	31 Dec 2017	13F
Schonfeld Strategic Advisors LLC	13F	Company	0.04%	84,356	$2,961,000	—	31 Dec 2017	13F
BAILARD, INC.	13F	Company	0.04%	79,000	$2,773,000	—	31 Dec 2017	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.04%	74,421	$2,613,000	—	31 Dec 2017	13F
EMORY UNIVERSITY	13F	Company	0.03%	63,013	$2,212,000	—	31 Dec 2017	13F
Bank of New York Mellon Corp	13F	Company	0.03%	57,388	$2,015,000	—	31 Dec 2017	13F
Iguana Healthcare Management, LLC	13F	Company	0.03%	50,000	$1,755,000	—	31 Dec 2017	13F
Matisse Capital	13F	Company	0.02%	46,734	$1,640,000	—	31 Dec 2017	13F
Spark Investment Management LLC	13F	Company	0.02%	40,200	$1,411,000	—	31 Dec 2017	13F
Granite Point Capital Management, L.P.	13F	Company	0.02%	30,000	$1,053,000	—	31 Dec 2017	13F
TIAA CREF INVESTMENT MANAGEMENT LLC	13F	Company	0.02%	29,671	$1,041,000	—	31 Dec 2017	13F
DEUTSCHE BANK AG\	13F	Company	0.01%	26,188	$918,000	—	31 Dec 2017	13F
MORGAN STANLEY	13F	Company	0.01%	25,738	$904,000	—	31 Dec 2017	13F
A.R.T. Advisors, LLC	13F	Company	0.01%	25,534	$896,000	—	31 Dec 2017	13F
TWO SIGMA INVESTMENTS, LP	13F	Company	0.01%	23,601	$828,000	—	31 Dec 2017	13F
TEACHERS ADVISORS, LLC	13F	Company	0.01%	21,534	$756,000	—	31 Dec 2017	13F
WEXFORD CAPITAL LP	13F	Company	0.01%	20,000	$702,000	—	31 Dec 2017	13F
PARAMETRIC PORTFOLIO ASSOCIATES LLC	13F	Company	0.01%	19,975	$701,000	—	31 Dec 2017	13F
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM	13F	Company	0.01%	18,730	$657,000	—	31 Dec 2017	13F
Swiss National Bank	13F	Company	0.01%	18,400	$646,000	—	31 Dec 2017	13F
BARCLAYS PLC	13F	Company	0.01%	14,574	$512,000	—	31 Dec 2017	13F
ALLIANCEBERNSTEIN L.P.	13F	Company	0.01%	13,400	$470,000	—	31 Dec 2017	13F
NEW YORK STATE COMMON RETIREMENT FUND	13F	Company	0.01%	12,700	$446,000	—	31 Dec 2017	13F
GSA CAPITAL PARTNERS LLP	13F	Company	0.01%	10,900	$383,000	—	31 Dec 2017	13F

Institutional Holders of Wave Life Sciences Ltd. - Ordinary Shares, no par value (WVE) as of Q1 2018

As of 31 Mar 2018, Wave Life Sciences Ltd. - Ordinary Shares, no par value (WVE) was held by 79 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 23,663,816 shares. The largest 10 holders included RA CAPITAL MANAGEMENT, LLC, Redmile Group, LLC, PRICE T ROWE ASSOCIATES INC /MD/, EcoR1 Capital, LLC, JANUS HENDERSON GROUP PLC, Boxer Capital, LLC, FMR LLC, BB BIOTECH AG, BlackRock Inc., and BRIDGER MANAGEMENT, LLC. This page lists 79 institutional shareholders reporting positions in this security for the Q1 2018 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q1 2018 vs Q4 2017 Across Filers

Q4 2017 holders

Q1 2018 holders

Holder diff

Investor	Q4 2017 Shares	Q1 2018 Shares	Share Diff	Share Chg %	Q4 2017 Value $	Q1 2018 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.